Trial · NCT00858637
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Active Comparison Phase | STARTED | MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase | 127 | |
| Active Comparison Phase | STARTED | MCI-196 (Active) + Simvastin (Placebo)/ Withdrawal Phase | 0 | |
| Active Comparison Phase | STARTED | MCI-196 (Placebo) + Simvastin (Placebo)/ Withdrawal Phase | 0 | |
| Active Comparison Phase | STARTED | Simvastatin (Active) + MCI-196 (Placebo)/ Comparion Phase | 133 | |
| Active Comparison Phase | STARTED | Simvastin (Active) + MCI-196 (Placebo)/ Withdrawal Phase | 0 | |
| Active Comparison Phase | STARTED | Simvastin (Placebo) + MCI-196 (Placebo)/ Withdrawal Phase | 0 | |
| Active Comparison Phase | COMPLETED | MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase | 103 | |
| Active Comparison Phase | COMPLETED | MCI-196 (Active) + Simvastin (Placebo)/ Withdrawal Phase | 0 | |
| Active Comparison Phase | COMPLETED | MCI-196 (Placebo) + Simvastin (Placebo)/ Withdrawal Phase | 0 | |
| Active Comparison Phase | COMPLETED | Simvastatin (Active) + MCI-196 (Placebo)/ Comparion Phase | 115 | |
| Active Comparison Phase | COMPLETED | Simvastin (Active) + MCI-196 (Placebo)/ Withdrawal Phase | 0 | |
| Active Comparison Phase | COMPLETED | Simvastin (Placebo) + MCI-196 (Placebo)/ Withdrawal Phase | 0 | |
| Active Comparison Phase | NOT COMPLETED | MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase | 24 | |
| Active Comparison Phase | NOT COMPLETED | MCI-196 (Active) + Simvastin (Placebo)/ Withdrawal Phase | 0 | |
| Active Comparison Phase | NOT COMPLETED | MCI-196 (Placebo) + Simvastin (Placebo)/ Withdrawal Phase | 0 | |
| Active Comparison Phase | NOT COMPLETED | Simvastatin (Active) + MCI-196 (Placebo)/ Comparion Phase | 18 | |
| Active Comparison Phase | NOT COMPLETED | Simvastin (Active) + MCI-196 (Placebo)/ Withdrawal Phase | 0 | |
| Active Comparison Phase | NOT COMPLETED | Simvastin (Placebo) + MCI-196 (Placebo)/ Withdrawal Phase | 0 | |
| Placebo-controlled Withdrawal Phase | STARTED | MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase | 0 | |
| Placebo-controlled Withdrawal Phase | STARTED | MCI-196 (Active) + Simvastin (Placebo)/ Withdrawal Phase | 49 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00858637/flow